Marsha Grattan

发表

Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes1

M. Burdick, R. Strieter, M. Cameron, 2000, The Journal of Immunology.

Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci.

Q. Mi, C. Meagher, T. Delovitch, 2002, Diabetes.

This information is current as Diabetes Associated with Progression to Type I and the CCR 5 Receptor in the Pancreas Is Differential Expression of CC Chemokines

M. Burdick, R. Strieter, M. Cameron, 2000 .

Regulation of FAS Ligand Expression during Activation-Induced Cell Death in T Cells by p38 Mitogen-Activated Protein Kinase and C-Jun Nh2-Terminal Kinase

Jian Zhang, D. Laird, Qing Shao, 2000, The Journal of experimental medicine.

Isolation and sequence analysis of the Pseudomonas syringae pv. tomato gene encoding a 2,3-diphosphoglycerate-independent phosphoglyceromutase

V. Morris, D. Cuppels, M. Grattan, 1995, Journal of Bacteriology.

Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes.

Q. Mi, T. Delovitch, K. Salojin, 2004, Endocrinology.

Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well.

R. Khokha, I. Macdonald, E. Schmidt, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice.

J. Nagle, D. Ly, YOUHAI H. Chen, 2003, Diabetes.

Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate.

R. Khokha, K. Luzzi, I. Macdonald, 1995, Cancer research.

Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth

I. Macdonald, E. Schmidt, V. Morris, 1994, Clinical & Experimental Metastasis.

Survive and Extravasate Fate of Melanoma Cells Entering the Microcirculation : Over 80 % Updated

R. Khokha, K. Luzzi, I. Macdonald, 2006 .